Finance

Lists
OGN:NYSE
Organon & Co
US$ १३.९०
+०.०७%
(+०.०१००) 1D
US$ १३.९०
०.००% (०.००)
After hours
Closed: नोभेम्बर १२, १६:००:०४ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OGN...
Open
US$ १३.८७
High
US$ १३.९०
Low
US$ १३.८७
Mkt. cap
३.६५ अरब
Avg. vol.
२४.३२ लाख
Volume
२९.०४ लाख
Dividend
०.५८%
Quarterly dividend
US$ ०.०२
Ex-dividend date
२०२६ अगस्ट १४
P/E ratio
१८.०८
52-wk high
US$ १३.९०
52-wk low
US$ ५.६९
EPS
US$ ०.७७
Beta
१.५३
Shares outstanding
२६.२६ करोड
No. of employees
१० हजार
Open
US$ १३.८७
High
US$ १३.९०
Low
US$ १३.८७
Mkt. cap
३.६५ अरब
Avg. vol.
२४.३२ लाख
Volume
२९.०४ लाख
Dividend
०.५८%
Quarterly dividend
US$ ०.०२
Ex-dividend date
२०२६ अगस्ट १४
P/E ratio
१८.०८
52-wk high
US$ १३.९०
52-wk low
US$ ५.६९
EPS
US$ ०.७७
Beta
१.५३
Shares outstanding
२६.२६ करोड
No. of employees
१० हजार
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees१० हजार
Founded१९२३
HeadquartersJersey City, न्यु जर्सी, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst
Recommendation
Action
Price target
Projected
Date
Navann Ty
Exane BNP Paribas
Hold
Downgraded
US$ १४.००
+०.७%
04/28/2026
David Amsellem
Piper Sandler
Hold
Upgraded
US$ १४.००
+०.७%
04/28/2026
Umer Raffat
Evercore ISI
Hold
Maintained
-
-
04/10/2026
Terence Flynn
Morgan Stanley
Hold
Maintained
US$ ९.००
-३५.३%
04/10/2026
Glen Santangelo
Barclays
Sell
Maintained
US$ ८.००
-४२.४%
02/24/2026
Chris Schott
J.P. Morgan
Sell
Maintained
US$ ११.००
-२०.९%
02/13/2026
Jason Gerberry
Bank of America Securities
Sell
Maintained
-
-
02/13/2026
Last report
२०२६ अक्टोबर ३०
Fiscal period
Q3 2026
US$ ०.९४ / US$ ०.९५
-०.६८%miss
Revenue / Est. (USD)
१.५७ अरब / १.५८ अरब
-०.०६%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१.५१ अरब
१.४६ अरब
१.५६ अरब
१.५७ अरब
Cost of goods sold
७४.१० करोड
६७.०० करोड
७१.१० करोड
७०.५० करोड
Cost of revenue
७४.१० करोड
६७.०० करोड
७१.१० करोड
७०.५० करोड
Research and development expenses
९.१० करोड
९.३० करोड
९.०० करोड
८.३० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४३.१० करोड
४२.४० करोड
४३.४० करोड
४२.१० करोड
Operating expense
५२.२० करोड
५१.७० करोड
५२.४० करोड
५०.४० करोड
Total operating expenses
१.२६ अरब
१.१९ अरब
१.२४ अरब
१.२१ अरब
Operating income
२४.४० करोड
२७.३० करोड
३२.३० करोड
३६.५० करोड
Other non operating income
-१.८० करोड
१.५० करोड
-३०.०० लाख
१.२० करोड
EBT including unusual items
-१४.८० करोड
२१.३० करोड
१८.३० करोड
२५.५० करोड
EBT excluding unusual items
१०.३० करोड
१७.०० करोड
२१.०० करोड
२६.५० करोड
Income tax expense
५.७० करोड
६.७० करोड
७.५० करोड
९.१० करोड
Effective tax rate
-३८.५१%
३१.४६%
४०.९८%
३५.६९%
Other operating expenses
-
-
-
-
Net income
-२०.५० करोड
१४.६० करोड
१०.८० करोड
१६.४० करोड
Net profit margin
-१३.६०%
१०.००%
६.९३%
१०.४२%
Earnings per share
०.६३
०.७१
०.८५
०.९४
Interest and investment income
-
-
-
-
Interest expense
-१२.१० करोड
-११.१० करोड
-१०.८० करोड
-१०.६० करोड
Net interest expenses
-१२.१० करोड
-११.१० करोड
-१०.८० करोड
-१०.६० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
३४.०० करोड
३५.९० करोड
४०.३० करोड
४४.७० करोड
Gain or loss from assets sale
-
-८.१० करोड
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू